Citation Impact
Citing Papers
The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome
2008
Epidemiology and causes of preterm birth
2008 Standout
The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting
2011 Standout
Metabolic and Endocrine Effects of a Polyunsaturated Fatty Acid-Rich Diet in Polycystic Ovary Syndrome
2004
Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas
1983
The Pancreas Is Altered by In Utero Androgen Exposure: Implications for Clinical Conditions Such as Polycystic Ovary Syndrome (PCOS)
2013
High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence
2003 Standout
Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
2005
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
2004 Standout
Cardiovascular Disease and Risk Factors in PCOS Women of Postmenopausal Age: A 21-Year Controlled Follow-Up Study
2011
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
1998
Prediction models for insulin resistance in the polycystic ovary syndrome
2000
Patients' attitudes to medical and psychosocial aspects of care in fertility clinics: findings from the Copenhagen Multi-centre Psychosocial Infertility (COMPI) Research Programme
2003
High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome
1999
BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
2014
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
2017
Stress and marital satisfaction among women before and after their first cycle of in vitro fertilization and intracytoplasmic sperm injection
2001
Prevalence of psychiatric disorders in infertile women and men undergoing in vitro fertilization treatment
2008
Cellular Insulin Resistance in Adipocytes from Obese Polycystic Ovary Syndrome Subjects Involves Adenosine Modulation of Insulin Sensitivity1
1997
Effects of culture conditions on IVF outcome
2004
Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus.
1995
MetforminVersusEthinyl Estradiol-Cyproterone Acetate in the Treatment of Nonobese Women with Polycystic Ovary Syndrome: A Randomized Study
2003
Current Developments in the Molecular Genetics of the Polycystic Ovary Syndrome
1998
Characterizing Discrete Subsets of Polycystic Ovary Syndrome as Defined by the Rotterdam Criteria: The Impact of Weight on Phenotype and Metabolic Features
2006
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study1
1998 Standout
Effect of ovarian suppression on glucose metabolism of young lean women with and without ovarian hyperandrogenism
1999
Prolactinomas and Pregnancy
2005
ESHRE guideline: management of women with endometriosis
2014 Standout
Effects of metformin and ethinyl estradiol–cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome
2005
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis
2010
The Cardiovascular Risk of Young Women with Polycystic Ovary Syndrome: An Observational, Analytical, Prospective Case-Control Study
2004
A Comparative Review of the Tolerability Profiles of Dopamine Agonists in the Treatment of Hyperprolactinaemia and Inhibition of Lactation
1996
High Prevalence of Polycystic Ovaries and Associated Clinical, Endocrine, and Metabolic Features in Women with Previous Gestational Diabetes Mellitus
1998
Defining ConstantVersusVariable Phenotypic Features of Women with Polycystic Ovary Syndrome Using Different Ethnic Groups and Populations
2006
Fasting Insulin Pulsatile Secretion in Lean Women with Polycystic Ovary Syndrome
2008
Review of unexplained infertility and obstetric outcome: a 10 year review
2001
Changing patterns of low birthweight and preterm birth in the United States, 1981–98
2002
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Obesity
2005 Standout
Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables
1994
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Androgen Excess Produces Systemic Oxidative Stress and Predisposes to β-Cell Failure in Female Mice
2010
Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet
2003
Combined oral contraceptives in the treatment of polycystic ovary syndrome
2005
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Polycystic ovary syndrome and its developmental origins
2007
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Polycystic Ovary Syndrome
1995 Standout
Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome
2006
A Randomized Trial of Planned Cesarean or Vaginal Delivery for Twin Pregnancy
2013
The Metabolic Syndrome and Cardiovascular Risk
2010 Standout
Two-year treatment with oral contraceptives in hyperprolactinemic patients
1998
Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
2010
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
2008 Standout
Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass
2005
Mechanisms linking obesity to insulin resistance and type 2 diabetes
2006 StandoutNature
Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries
2004
The Risk of Major Birth Defects after Intracytoplasmic Sperm Injection and in Vitro Fertilization
2002
The genetic basis of polycystic ovary syndrome
1997
Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity
2010
Pre-eclampsia
2010 Standout
Endocrine and Metabolic Effects of MetforminVersusEthinyl Estradiol-Cyproterone Acetate in Obese Women with Polycystic Ovary Syndrome: A Randomized Study1
2000
Polycystic Ovary Syndrome
2005 Standout
How viable are zygotes in which the PN are still intact at 25 hours? Impact on the choice of embryo for transfer
2007
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
2006
Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS
2007
New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility
2002
Developmental origin of polycystic ovary syndrome - a hypothesis
2002
Altered Vascular Function in Young Women with Polycystic Ovary Syndrome
2002
β-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
2005
Exercise therapy in polycystic ovary syndrome: a systematic review
2010
Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study
2002
Association of Insulin Gene VNTR Polymorphism with Polycystic Ovary Syndrome
2002
The Metabolic Syndrome in Polycystic Ovary Syndrome
2007
The embryologist as counsellor during assisted reproduction procedures
2005
Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome
2000
Less depressed or less forthcoming? Self-report of depression symptoms in women preparing for in vitro fertilization
2012
Gender differences in glucose homeostasis and diabetes
2017
Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up
2011
Perinatal Outcomes in Singletons Following In Vitro Fertilization: A Meta-Analysis
2004
Acute insulin response to intravenous glucagon in polycystic ovary syndrome
1998
Polycystic Ovary Syndrome in the Adolescent
2009
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
2008 Standout
Obesity and the polycystic ovary syndrome
2002
Polycystic ovary syndrome
2016 Standout
Inappropriate Gonadotropin Secretion in Polycystic Ovary Syndrome: Influence of Adiposity1
1997
Prevalence and Predictors of Risk for Type 2 Diabetes Mellitus and Impaired Glucose Tolerance in Polycystic Ovary Syndrome: A Prospective, Controlled Study in 254 Affected Women1
1999 Standout
Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome.
1996
Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome
1997
The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women
1994
ESHRE guideline: routine psychosocial care in infertility and medically assisted reproduction—a guide for fertility staff: Figure 1
2015 Standout
Phenotypic characteristics according to insulin sensitivity in non-obese Korean women with polycystic ovary syndrome
2007
Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies
1987
Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome
2006
Gender perspective on quality of life, comparisons between groups 4–5.5 years after unsuccessful or successful IVF treatment
2010
Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study
2007
Incretin levels in polycystic ovary syndrome
2008
Environmental epigenomics and disease susceptibility
2007 Standout
DNA methylation and human disease
2005 Standout
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
2003 Standout
Long-term health consequences of PCOS
2002
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome
2004
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
2008
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
2010
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
2012
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
2010
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999
Polycystic Ovary Syndrome and Ovulation Induction
2007
The role of androgens in metabolism, obesity, and diabetes in males and females
2015
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
2007
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
1996
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Nutrition and Reproduction
1985
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Hyperprolactinemia
1983
Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism.
1996
Polycystic Ovary Syndrome and Cardiovascular Disease: A Premature Association?
2003
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
1997 Standout
Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
2015
Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
1995
Estados emocionais de casais submetidos à fertilização in vitro
2009
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Advances in the Treatment of Prolactinomas
2006
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
2007
Early origins of polycystic ovary syndrome
2005
Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
2007
Ovarian Function and Metabolic Factors in Women with Oligomenorrhea Treated with Metformin in a Randomized Double Blind Placebo-Controlled Trial
2002
Cardiometabolic Aspects of the Polycystic Ovary Syndrome
2012
Restoration of Reproductive Potential by Lifestyle Modification in Obese Polycystic Ovary Syndrome: Role of Insulin Sensitivity and Luteinizing Hormone1
1999
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
2003
Medical Waiting Periods: Imminence, Emotions and Coping
2010
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
2003
American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome
2005
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
The Metabolic Syndrome
2008 Standout
Insulin Sensitivity in Women with Polycystic Ovary Syndrome
2004
Safe prevention of the primary cesarean delivery
2014 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
Pituitary Tumors Secreting Growth Hormone and Prolactin
1986
Metabolic effects of oral contraceptives in women with polycystic ovary syndrome.
1995
Transvaginal ultrasonographic findings in the uterus and the endometrium: Low prevalence of leiomyoma in a random sample of women age 25–40 years
2000
Role of Brain Insulin Receptor in Control of Body Weight and Reproduction
2000 StandoutScience
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
1996
Works of T. Bergh being referenced
Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours
1978
Psychological reactions during in-vitro fertilization: similar response pattern in husbands and wives
1998
Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis
1998
Deliveries and children born after in-vitro fertilisation in Sweden 1982–95: a retrospective cohort study
1999
Elevated ambulatory day-time blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state?
1996
CV 205‐502: A NEW LONG‐ACTING DRUG FOR INHIBITION OF PROLACTIN HYPERSECRETION
1987
Transvaginal sonographic evaluation of endometrial growth and texture in spontaneous ovulatory cycles—a descriptive study
1993
Construction of an evidence-based integrated morphology cleavage embryo score for implantation potential of embryos scored and transferred on day 2 after oocyte retrieval
2006
Distress level in men undergoing intracytoplasmic sperm injection versus in-vitro fertilization
1998
SERUM PROLACTIN AND GONADOTROPHIN LEVELS BEFORE AND AFTER LUTEINIZING HORMONE‐RELEASING HORMONE IN THE INVESTIGATION OF AMENORRHOEA
1978
Effects of bromocriptine-induced pregnancy on prolactin-secreting pituitary tumours
1981
BROMOCRIPTINE‐INDUCED PREGNANCIES IN WOMEN WITH LARGE PROLACTINOMAS
1982
Enhanced early insulin response to glucose in relation to insulin resistance in women with polycystic ovary syndrome and normal glucose tolerance.
1994
Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome.
1995
The long-acting dopamine agonist pergolide mesylate for treatment of hyperprolactinaemia.
1985